Surrogate end points for survival in the target treatment of advanced non-small-cell lung cancer with gefitinib or erlotinib

被引：0
|
作者：
Xiaoqin Li
Shan Liu
Hangang Gu
Deqiang Wang
机构：
[1] Affiliated Hospital of Jiangsu University,Cancer Therapy Center
[2] Affiliated Hospital of Jiangsu University,Research Room of Oncologic Emergency, Emergency Internal Medicine
来源：
Journal of Cancer Research and Clinical Oncology | 2012年 / 138卷
关键词：
Erlotinib; Gefitinib; Non-small-cell lung cancer; Median survival time;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1963 / 1969
页数：6
相关论文
共 50 条
  • [1] Surrogate end points for survival in the target treatment of advanced non-small-cell lung cancer with gefitinib or erlotinib
    Li, Xiaoqin
    Liu, Shan
    Gu, Hangang
    Wang, Deqiang
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (11) : 1963 - 1969
  • [2] Treatment of Non-Small-Cell Lung Cancer with Erlotinib or Gefitinib
    Cataldo, Vince D.
    Gibbons, Don L.
    Perez-Soler, Roman
    Quintas-Cardama, Alfonso
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (10): : 947 - 955
  • [3] Chemotherapy and intercalated gefitinib or erlotinib in the treatment of advanced non-small-cell lung cancer
    Rossi, Antonio
    La Salvia, Anna
    Di Maio, Massimo
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2017, 11 (03) : 171 - 180
  • [4] Erlotinib or Gefitinib for Non-Small-Cell Lung Cancer
    Yusuf, Syed W.
    Kim, Peter
    Durand, Jean-Bernard
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (24): : 2367 - 2367
  • [5] Erlotinib in advanced non-small-cell lung cancer after gefitinib failure
    Zheng-Tao Zhou
    Xin-Hua Xu
    Qing Wei
    Ming-qian Lu
    Jie Wang
    Cai-Hong Wen
    [J]. Cancer Chemotherapy and Pharmacology, 2009, 64 : 1123 - 1127
  • [6] Comparison of Gefitinib and Erlotinib for Patients with Advanced Non-Small-Cell Lung Cancer
    Lee, Jin Hwa
    Lee, Kyoung Eun
    Ryu, Yon Ju
    Chun, Eun Mi
    Chang, Jung Hyun
    [J]. TUBERCULOSIS AND RESPIRATORY DISEASES, 2009, 66 (04) : 280 - 287
  • [7] Erlotinib in advanced non-small-cell lung cancer after gefitinib failure
    Zhou, Zheng-Tao
    Xu, Xin-Hua
    Wei, Qing
    Lu, Ming-qian
    Wang, Jie
    Wen, Cai-Hong
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (06) : 1123 - 1127
  • [8] Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer
    Passaro, Antonio
    Alesini, Daniele
    Pochesci, Alessia
    Cortesi, Enrico
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2014, 14 (05) : 646 - 650
  • [9] Gefitinib in the treatment of advanced non-small-cell lung cancer
    Reck, Martin
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (04) : 401 - 412
  • [10] Erlotinib or Gefitinib for Non-Small-Cell Lung Cancer REPLY
    Cataldo, Vince D.
    Gibbons, Don L.
    Quintas-Cardama, Alfonso
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (24): : 2368 - 2368
12345